1. Home
  2. FGBIP vs KLTOW Comparison

FGBIP vs KLTOW Comparison

Compare FGBIP & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBIP

First Guaranty Bancshares Inc.

HOLD

Current Price

$17.99

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Klotho Neurosciences Inc. Warrant

KLTOW

Klotho Neurosciences Inc. Warrant

HOLD

Current Price

$0.07

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBIP
KLTOW
Founded
N/A
N/A
Country
United States
United States
Employees
339
3
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
FGBIP
KLTOW
Price
$17.99
$0.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
FGBIP
KLTOW
Relative Strength Index (RSI) 69.92 41.28
Support Level $17.92 $0.07
Resistance Level $18.03 $0.09
Average True Range (ATR) 0.37 0.01
MACD 0.03 -0.00
Stochastic Oscillator 33.86 25.51

Price Performance

Historical Comparison
FGBIP
KLTOW

About FGBIP First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: